Anna Petryk, MD

Professor, Division of Pediatric Endocrinology

Anna Petryk

Contact Info

Office Phone 612-624-5409

Mobile Phone 612-626-5262

Office Address:
Pediatric Endocrinology
6th Floor East Building
2450 Riverside Ave
Minneapolis, MN 55454

Mailing Address:
Div of Pediatric Endocrinology
6th Floor East Building
8952D (Campus Delivery Code)
2450 Riverside Ave
Minneapolis, MN 55454

Professor, Division of Pediatric Endocrinology

Pediatric Endocrinologist

Medical University, Wroclaw, Poland, Ninewells Hospital, United Kingdom

Miami Children's Hospital, Miami FL

Duke University Medical Center, Durham, NC


Dr. Petryk is a Professor of Pediatrics and the Director of the Comprehensive Pediatric Bone Health Program. She attended medical school in Wroclaw, Poland and Dundee, U.K., completed her Pediatric Residency at Miami Children's Hospital, and Pediatric Endocrinology Fellowship at Duke University. She joined the Division of Pediatric Endocrinology in 1999. Dr. Petryk provides clinical care in general pediatric endocrinology, specializing in childhood bone diseases and endocrine late effects in survivors of childhood cancer and recipients of bone marrow transplantation.

Awards & Recognition

  • Best Doctors in America® (2011-2012, 2013)


Research Summary/Interests

Dr. Petryk's research interest is in bone disorders in children, with special emphasis on early interventions to attain adequate bone density during childhood and adolescence, preventive and treatment strategies for children at risk for bone fragility due to osteoporosis, bone loss after cancer treatment, bone marrow transplantation, chronic diseases (gastrointestinal, liver, renal, rheumatic, long term use of glucocorticoids), osteogenesis imperfecta, rickets and other disorders. Her research also focuses on the development of diagnostic and monitoring tools to improve therapeutic outcomes.



Pediatric Specialty Care-Explorer Clinic

Board Certifications

Pediatric Endocrinology

Clinical Interests

Childhood bone diseases; rickets; calcium abnormalities; endocrine late effects (growth and growth hormone treatment, pubertal development, thyroid function, adrenals) in survivors of childhood cancers and/or bone marrow transplantation, including patients with osteogenesis imperfecta, osteopetrosis, Fanconi anemia, and adrenoleukodystrophy.